Search
- Dec 11, 2023
Gracell's founder explains his company's rationale for BCMA + CD19 in both myeloma and lupus
William Cao describes how the same product might be used for cancer and lupus, and explains the idea behind FasTCAR manufacturing.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A